Dr Mehran Moazen, currently Associate Professor of Biomedical Engineering at UCL Mechanical Engineering, has been recognised by the Institute of Mechanical Engineering (IMechE) through his recent appointment as a Fellow of the Institute.
Dr Moazen is also celebrating another fellowship award – an EPSRC Open Fellowship for his multidisciplinary project known as CranioMech. CranioMech aims to address the current lack of knowledge in treatments of craniofacial conditions mostly affecting children. Craniosynostosis (CS), an increasingly common condition affecting the skull growth of infants, has seen a rise in cases across Europe over the past 30 years. Dr Moazen’s project will utilise a combination of advanced approaches in order to develop a revolutionary treatment for CS and attempt to resolve the unknown mechanobiology.
On his award win, Dr Moazen said:
I am delighted to have been awarded this prestigious fellowship. This is indeed an exciting piece of work that I truly believe can revolutionise the future of craniofacial surgery for children. In a series of pilot in vivo animal studies, we have shown the potential of a future therapy for craniosynostosis. This project will enable us to scale up our exciting pilot data to test the potential clinical translation of our approach.
The project has been awarded a grant of over £1.5 million and begins this month.
Further links
UCL Ocean Health Challenge Winners Announced
Find out which students impressed the judges with their creative ideas around tackling ocean plastic pollution.
17 Jun 2025
Blog: AI-Prosperity Alignment: A Pathway to a Flourishing Future
We often imagine technology providing quick fixes to big challenges, but what if we rethink how AI and prosperity can combine to foster a more inclusive, sustainable, and equitable future?
17 Jun 2025
Digital Transformation in ATMP Manufacturing held at UCL East on 16 May
The event convened over 60 invited stakeholders across industry, NHS, academia, and regulation to address key barriers in the scaling of CAR-T and other advanced therapy medicinal products (ATMPs).
17 Jun 2025
